查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863073

按設備類型、最終用戶、技術、應用和適應症分類的骨內輸注設備市場—2025年至2032年全球預測

Intraosseous Infusion Devices Market by Device Type, End User, Technology, Application, Indication - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，骨內注射裝置市場將成長至 90.1 億美元，複合年成長率為 6.51%。

關鍵市場統計數據
基準年 2024 54.3億美元
預計年份：2025年 57.9億美元
預測年份 2032 90.1億美元
複合年成長率 (%) 6.51%

臨床和商業性因素推動了骨內輸液裝置在重症監護和營運環境中的應用。

骨內輸液裝置在急診護理中發揮著至關重要的作用，因為血管通路至關重要且時間緊迫。當周邊靜脈通路無法使用或需要快速復甦時，醫護人員會依靠這些裝置來確保在急診、院前急診、手術室、加護病房甚至野戰醫療中建立可靠的骨內通路。技術進步使該領域從基本的手動針頭發展到機械穿刺系統和電池驅動鑽頭，旨在縮短穿刺時間、降低穿刺誤差並提高高壓臨床環境下的首次穿刺成功率。

本篇採納分析為影響設備選擇和採納的臨床需求、技術差異化和採購考量提供了一個架構。它重點關注設備的人體工學、插入可靠性、臨床醫生培訓以及與下游工作流程（例如液體復甦、藥物給藥和診斷採樣）的交互作用。本文旨在為臨床醫生、採購主管和產品負責人提供一份簡明指南，以評估設備功能如何與治療路徑、監管要求和營運限制相符。在此背景下，後續章節將討論結構性變化、關稅的影響、細分市場洞察、區域趨勢、競爭格局以及基於一手和二手資訊的實用建議。

技術創新、不斷發展的臨床醫生培訓以及供應鏈韌性如何共同重塑骨內裝置的選擇和臨床應用。

骨內器械產業正經歷一系列變革，這些變革正在重塑產品設計重點、採購標準和臨床工作流程。插入機制和便攜性的進步正在縮小院內和院外操作能力之間的差距。新一代器械越來越注重單手操作、深度可控插入以及增強的整合安全功能，以減少併發症並簡化訓練。同時，採購部門要求器械能夠在包括成人、兒童、新生兒和老年人在內的不同患者群體中提供一致的性能，這迫使製造商擴展產品系列併採用模組化系統。

同時，為降低供應中斷的風險，醫療器材供應鏈和製造策略正朝著地域多角化和組件冗餘的方向發展。支付者和醫療系統日益重視醫療品質指標和器材相關不利事件報告，使得臨床證據的產生和上市後監測成為越來越重要的差異化因素。此外，基於模擬的培訓和能力檢驗計畫的普及提高了臨床醫生的信心和首次手術成功率，從而促進了這些技術在急診醫療服務和門診手術領域的廣泛應用。這些協同趨勢為製造商在使用者體驗、服務提供和證據包方面進行創新創造了機會，同時也迫使採購者評估整體擁有成本、臨床結果和生命週期支援。

評估關稅趨勢對骨內輸注裝置的籌資策略、本地化生產和臨床應用的影響

美國2025年可能加徵關稅，為採購、製造和購買環節的相關人員增加了一層政策風險，因為關稅政策的變化可能會對複雜的醫療技術供應鏈產生連鎖反應。針對醫療器材組件和成品的關稅可能會立即給依賴進口設備和原料的企業帶來成本壓力，促使採購部門重新評估供應商合約、庫存緩衝和國內採購方案。作為應對措施，一些製造商可能會加快關鍵製造環節的在地化進程，或加強與國內契約製造製造商的合作關係，以確保價格穩定和交貨期。

除了直接的價格影響外，關稅還會影響產品組合、包裝和運輸路線選擇等策略決策，以最大限度地降低關稅負擔。經銷商和集團採購組織可能會尋求修改合約條款，以分擔關稅相關的成本波動；醫療機構可能會調整採購計劃，以利用現有庫存或協商價格。重點，關稅將促使企業投資於馬達、電池和特殊合金等關鍵零件的替代供應鏈，從而影響設備設計和前置作業時間。從臨床角度來看，政策引發的供應中斷可能會限制關鍵時期設備的可用性，因此冗餘備份和緊急時應對計畫至關重要。總而言之，關稅政策的發展應促使製造商和採購商積極主動地實現採購管道多元化，檢驗替代供應商，並制定正式的升級程序，以維持臨床服務的連續性並降低營運風險。

細分市場分析揭示了設備類型、最終用戶環境、技術選擇、臨床應用和適應症如何驅動採購和採用差異化。

詳細的細分分析揭示了設備技術和最終用戶環境如何驅動產品需求和採用路徑。基於設備類型，相關人員評估各種選項，例如電池驅動鑽頭、手動針頭、氣動和彈簧式自動插入裝置。每種配置在速度、控制和使用者熟悉度方面各有優劣。基於最終用戶，配置包括門診中心、急診醫療服務、醫院和軍隊。在門診中心中，重點是門診手術中心和醫生診所，而急診醫療服務則涵蓋空中救護和院前急診服務。醫院進一步細分為急診室、加護病房(ICU) 和手術室。急診室本身又分為成人急診和兒科急診科，ICU 又分為成人 ICU、新生兒 ICU 和兒科 ICU。手術室的應用場景分為一般外科和整形外科，而軍事應用則區分為戰地支援醫院和野戰醫療單位。

從技術角度來看，設備的選擇取決於特定環境所需的性能範圍。依技術分類，市面上的設備包括電池驅動、手動、氣動和彈簧驅動設備；電池驅動解決方案又可細分為可充電電池和一次性電池；氣動系統則分為空氣驅動和氣體驅動兩種。應用方面的具體要求進一步縮小了產品選擇範圍。根據應用領域，臨床醫生會選擇用於心臟麻痹、腫瘤、整形外科、小兒科和創傷護理的設備。心臟麻痹的應用場景包括院內和院外；腫瘤科應用應涵蓋骨髓切片檢查和化療支持；整形外科應涵蓋骨折修復和關節重建；小兒科應針對兒童、嬰兒和新生兒；創傷護理應用應涵蓋鈍性創傷和穿透性創傷。最後，臨床適應症也至關重要。根據適應症，器械的選擇取決於多種情況，例如心臟麻痹、低血容量性休克、膿毒症和創傷，每種情況都有其獨特的手術時機、入路部位選擇和後續治療需求。整合這些細分維度表明，一刀切的產品很少能滿足各種不同的應用場景，客製化的設計、培訓和支援模式對於器械的推廣至關重要。

不同地區在監管、採購和臨床培訓方面的差異將如何重塑骨內器械的產品策略和分銷模式？

區域趨勢將在塑造骨內輸注裝置的監管路徑、報銷框架、培訓系統和供應鏈結構方面發揮關鍵作用。在美洲，買家優先考慮的是快速整合到重症監護中、廣泛普及的模擬培訓中心以及透過綜合醫療保健系統和大型經銷商進行集中採購，他們更傾向於選擇具有強力臨床證據和可擴展服務模式的裝置。在歐洲、中東和非洲地區（EMEA），複雜的監管體系和多樣化的報銷政策造成了不同的市場准入條件。歐洲市場傾向於優先考慮臨床結果和上市後監測，而中東和北非地區（MENA）則更注重裝置的穩健性和供應的連續性，尤其是在偏遠和惡劣的環境中。在亞太地區，醫院的快速擴張、重症監護能力的提升以及大規模的軍事現代化項目正在推動市場需求，但打入市場策略必須考慮到不同的監管要求、當地的生產獎勵以及不同的臨床醫生培訓標準。

在全部區域，當地的製造能力、關稅制度和物流基礎設施都會影響前置作業時間和庫存策略。區域採購聯盟和競標流程傾向於那些能夠提供透明的生命週期支援和培訓夥伴關係的製造商。此外，臨床指南和院前急救模式的採用因地區而異，這會影響醫院急診和院前/軍事部署所需設備的細分。因此，制定能夠將設備性能與當地臨床工作流程、監管要求和採購機制相匹配的客製化價值提案，對於成功的區域策略至關重要。

對骨內植入裝置供應商的商業性成功所依據的證據、訓練和供應鏈合作夥伴關係進行競爭性分析

骨內植入器材領域的競爭格局呈現出多元化的格局，既有成熟的器材製造商，也有技術驅動的新興參與企業，還有提供硬體銷售、訓練和售後支援的服務型供應商。領先企業通常透過臨床證據、植入可靠性和全面的服務項目來脫穎而出，這些項目包括實踐培訓、模擬模組和能力檢驗。新興企業專注於特定領域的優勢，例如針對兒科患者最佳化的符合人體工學設計、適用於空中救護運輸的超緊湊型設計，以及用於輔助庫存管理和臨床記錄的整合遙測和追蹤功能。

為了整合分銷實力、臨床培訓能力和生產規模，夥伴關係和策略聯盟正變得越來越普遍。契約製造和目的地設備製造商 (OEM) 關係使技術驅動型新參與企業能夠加速市場進入，同時減少生產設施的資本投入。同時，採購部門和大型醫療系統透過優先選擇那些能夠提供長期採購協議、供應鏈透明度和完善的上市後監管的供應商，獲得了談判優勢。總而言之，競爭成功取決於始終如一的價值提案，該主張將差異化的設備性能與循證結果、法規遵從性和可擴展的服務相結合。

為製造商和醫療系統領導者提供切實可行的策略藍圖，以確保骨內裝置的臨床應用、供應連續性和基於實證醫學的差異化。

為了贏得臨床信任和採購優先權，產業領導者應採取多層次策略，平衡創新與業務連續性。首先，優先產生高品質的臨床證據，證明產品能夠提高首次手術成功率、減少植入併發症並顯著提升工作流程效率。這些證據應支持產品聲明，並納入臨床醫生培訓課程。其次，透過對替代組件供應商進行資格認證和評估區域製造夥伴關係關係，實現供應鏈多元化，從而降低關稅衝擊和物流中斷的風險。第三，設計可配置的產品系列和模組化培訓項目，以滿足從門診手術中心和診所到空中救護隊和戰地醫療支援部隊等不同終端用戶的需求。

此外，還需要投資於售後服務和數位化工具，以加強設備追蹤、功能評估和真實世界證據收集。這些服務可以鞏固客戶關係，並為報銷談判提供支援。積極與支付者、醫療系統和監管機構溝通，明確醫療設備分類，簡化推廣路徑。最後，將政策變化和供應中斷的情境規劃納入商業合約和庫存管理，以確保在風險較高時期臨床服務的連續性。落實這些措施將使製造商和經銷商能夠減少採購摩擦，加速臨床應用，並在不斷變化的環境中保持收入穩定。

採用透明的混合方法研究設計，整合了對臨床醫生的訪談、監管審查和供應鏈分析，以產生經證實有效的營運洞察。

本分析的研究途徑結合了與關鍵相關人員的初步定性研究、對監管和臨床文獻的系統性回顧以及有針對性的供應鏈分析，以確保獲得可靠且可操作的見解。初步研究包括對急診室、加護病房、空中救護服務、野戰醫療隊和門診手術中心的臨床醫生進行結構化訪談，以及與採購經理、培訓計畫主管和生產合作夥伴進行討論。這些對話旨在揭示醫療設備性能優先事項、培訓差距、採購標準和供應鏈薄弱環節。

二次研究回顧了臨床指南、醫療設備使用說明書、監管申報文件和已發布的上市後監測摘要，以支持臨床醫生報告的發現並了解醫療設備的安全性。供應鏈分析繪製了關鍵組件供應商、製造地和物流路線圖，以評估關稅變化帶來的風險並確定切實可行的緩解策略。在適當情況下，研究結果透過多方資訊來源的檢驗和專家小組審查得到驗證。調查方法包括機構層級採購合約的可用性不一以及培訓項目的採用率存在差異。透過納入不同類型的受訪者並清楚記錄不確定因素，供讀者在決策時參考，這些限制得到了緩解。

整合臨床、技術和營運因素，以明確骨內輸液裝置在急性照護環境中的永續價值提案

骨內輸注裝置是一個日益成熟但仍在不斷發展的領域，它融合了急診需求、技術創新和複雜的採購動態。其普及軌跡更取決於臨床證據、供應鏈韌性、訓練支援和監管完整性等因素所構成的生態系統，而非單一產品的特性。能夠整合這些要素並提供一致的價值提案（包括可證實的臨床獲益、可靠的供應和終端用戶培訓）的利益相關人員，將最有希望在急診醫學、加護治療、門診手術和軍事應用領域獲得持續的普及。

展望未來，隨著政策和貿易趨勢持續影響採購決策和成本結構，多元化和區域製造能力將成為重要的策略槓桿。同樣，醫療設備人體工學設計、插入可靠性以及模擬訓練等綜合服務的持續改進，將降低使用障礙並擴大臨床適應症。最終，製造商和醫療系統的成功將取決於能否將技術性能轉化為可衡量的臨床結果和營運可預測性，從而確保臨床醫生在時間緊迫、就醫難時擁有提供緊急醫療所需的工具和信心。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 引入一種電池驅動的自動骨內輸液系統，用於在緊急醫療環境中快速建立血管通路。
  • 將智慧感測器技術整合到骨內輸液裝置中，以監測流速並預防併發症。
  • 醫療設備製造商與創傷中心合作，改進骨內輸液設備的設計和培訓
  • 兒童和成人患者對可同時進行液體輸注的多部位骨內通路裝置的需求日益成長。
  • 監管部門的核准和臨床試驗結果推動了新一代骨內輸液針的商業化進程
  • 增加對微創骨內導管研發的投資，該導管採用增強型生物相容性塗層，用於感染控制。
  • 拓展照護現場於軍事和惡劣環境的床邊骨內輸液解決方案，以改善戰場創傷照護。
  • 繼續研究超細骨內針，以減輕插入疼痛並加快兒科急救復甦速度。
  • 開發一種具有預充式生理食鹽水鎖和自動壓力監測系統的整合式骨內輸液套件
  • 利用擴增實境（AR）技術指導，擴展遠距骨內輸液培訓的遠距教學項目

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的骨內輸注設備市場

  • 電池式鑽孔機
  • 手動針
  • 氣動
  • 彈簧式自動插入裝置

9. 依最終用戶分類的骨內輸液裝置市場

  • 門診治療中心
    • 門診手術中心
    • 醫生診所
  • 緊急醫療服務
    • 空中救護
    • 院前急救服務
  • 醫院
    • 急診室
      • 成人急診室
      • 兒科急診
    • 加護病房（ICU）
      • 成人加護病房
      • 新生兒加護病房
      • 兒科加護病房
    • 手術室
      • 一般外科
      • 整形外科
  • 軍隊
    • 戰鬥支援醫院
    • 野戰醫療隊

10. 依技術分類的骨內輸液裝置市場

  • 電池供電
    • 可充電電池
    • 免洗電池供電
  • 手動輸入
  • 氣動
    • 氣動
    • 汽油動力
  • 彈簧機構

第11章 依應用分類的骨內輸液裝置市場

  • 心臟麻痹
    • 在醫院裡
    • 醫院外
  • 腫瘤學
    • 骨髓切片檢查
    • 化療支持
  • 整形外科
    • 骨折修復
    • 關節重建
  • 孩子們
    • 孩子們
    • 嬰兒
    • 新生
  • 創傷
    • 鈍性創傷
    • 穿透性創傷

第12章 骨內輸注裝置市場（依適應症分類）

  • 心臟麻痹
  • 低血容性休克
  • 敗血症
  • 創傷

13. 按地區分類的骨內輸液裝置市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 骨內輸液裝置市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國骨內輸液裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Becton, Dickinson and Company
    • Teleflex Incorporated
    • Cook Group Incorporated
    • Vygon SA
    • ICU Medical, Inc.
    • Smiths Group plc
    • B. Braun Melsungen AG
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Waismed Strategic Technologies Ltd.
Product Code: MRR-F6513A06BE95

The Intraosseous Infusion Devices Market is projected to grow by USD 9.01 billion at a CAGR of 6.51% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.43 billion
Estimated Year [2025] USD 5.79 billion
Forecast Year [2032] USD 9.01 billion
CAGR (%) 6.51%

Introducing the clinical and commercial imperative driving intraosseous infusion device adoption across high-acuity care settings and operational environments

Intraosseous infusion devices occupy a critical niche in acute care delivery where vascular access is essential and time-sensitive. Clinicians rely on these devices to establish reliable intramedullary access when peripheral veins are inaccessible or when rapid resuscitation is required, and their adoption spans emergency departments, pre-hospital settings, operating theatres, critical care units, and military field medicine. Technological evolution has moved the field beyond basic manual needles to mechanized insertion systems and battery-driven drills designed to reduce insertion time and variability and to improve first-attempt success rates in high-stress clinical scenarios.

This introductory analysis frames the clinical need, technological differentiation, and procurement considerations that shape device selection and adoption. It underscores the interplay between device ergonomics, insertion reliability, clinician training, and downstream workflows such as fluid resuscitation, drug delivery, and diagnostic sampling. The objective is to provide a succinct orientation for clinicians, procurement leaders, and product strategists so they can evaluate how device characteristics align with care pathways, regulatory demands, and operational constraints. By setting this context, the subsequent sections explore structural shifts, tariff implications, segment-level insights, regional dynamics, competitive behaviors, and practical recommendations grounded in primary and secondary intelligence.

How technological innovation, clinician training evolution, and supply chain resilience are collectively redefining intraosseous device selection and clinical utilization

The intraosseous device landscape is experiencing a series of transformative shifts that reshape product design priorities, purchase criteria, and clinical workflows. Advances in insertion mechanisms and portability are narrowing the gap between in-hospital and pre-hospital capabilities, and next-generation devices increasingly emphasize single-handed operation, controlled depth insertion, and integrated safety features to limit complications and to streamline training. At the same time, procurement teams demand devices that deliver consistent performance across diverse patient populations, including adults, pediatrics, neonates, and geriatric patients, prompting manufacturers to broaden product portfolios and to introduce modular systems.

Concurrently, the supply chain and manufacturing strategies that underpin device availability have moved toward regionalization and component redundancy to mitigate disruption risk. Insurers and health systems are placing greater emphasis on care quality metrics and device-related adverse event reporting, which elevates clinical evidence generation and post-market surveillance as differentiating factors. Moreover, the diffusion of simulation-based training and competency validation programs has accelerated clinician confidence and first-pass success, which in turn supports wider adoption across emergency medical services and ambulatory surgical settings. These converging trends create opportunities for manufacturers to innovate on user experience, service offerings, and evidence packages while also compelling purchasers to evaluate total cost of ownership, clinical outcomes, and lifecycle support.

Assessing how anticipated tariff dynamics could influence sourcing strategies, manufacturing localization, and clinical availability of intraosseous infusion devices

Since tariff policy changes can cascade through complex medtech supply chains, potential United States tariff actions in 2025 introduce a layer of policy risk that stakeholders must evaluate across sourcing, manufacturing, and procurement. Tariffs that target device components or finished devices create immediate cost pressure for organizations that rely on imported instrumentation or raw materials, prompting procurement teams to reassess supplier contracts, inventory buffers, and domestic sourcing options. In response, some manufacturers may accelerate localization of critical manufacturing steps or deepen relationships with domestic contract manufacturers to preserve price stability and delivery timelines.

Beyond direct price effects, tariffs influence strategic choices such as product configuration, packaging, and the geographic routing of shipments to minimize duty exposure. Distributors and group purchasing organizations may seek revised contract clauses that allocate tariff-related cost changes, while health systems may adjust acquisition timelines to exploit existing inventory or negotiated pricing. Importantly, tariffs can also spur investment in alternative supply chains for key components like motors, batteries, and specialized alloys, which has implications for device design and lead times. From a clinical perspective, policy-driven supply interruptions risk constraining device availability in high-acuity moments, making redundancy and contingency planning essential. Taken together, tariff dynamics encourage a proactive posture among manufacturers and buyers to diversify sourcing, to validate alternative suppliers, and to formalize escalation procedures that preserve clinical continuity and mitigate operational risk.

Segment-level analysis revealing how device type, end-user environment, technology choices, clinical applications, and indications drive differentiated procurement and adoption dynamics

A granular segmentation lens reveals how device technology and end-user contexts dictate product requirements and adoption pathways. Based on Device Type, stakeholders evaluate options that include Battery Powered Drill, Manual Needles, Pneumatic, and Spring Loaded Auto Insert, with each configuration presenting distinct trade-offs in speed, control, and user learning curve. Based on End User, the spectrum of settings includes Ambulatory Care Centers, Emergency Medical Services, Hospitals, and Military; within Ambulatory Care Centers the focus narrows to Outpatient Surgical Centers and Physician Clinics, while Emergency Medical Services encompasses Air Ambulance and Pre-Hospital Emergency Services. Hospitals unpack further into Emergency Department, ICU, and Operating Room contexts; the Emergency Department itself splits into Adult Emergency Department and Pediatric Emergency Department, and the ICU delineates Adult ICU, Neonatal ICU, and Pediatric ICU. Operating Room use cases divide into General Surgery and Orthopedic Surgery, whereas Military applications differentiate between Combat Support Hospitals and Field Medical Units.

From a technology standpoint, device choice aligns with the performance envelope required for specific settings. Based on Technology, the market includes Battery Powered, Manual, Pneumatic, and Spring Mechanism devices, with Battery Powered solutions further segmented into Rechargeable Battery and Single Use Battery options, and Pneumatic systems differentiated by Air Driven and Gas Driven variants. Application-specific requirements further refine product selection. Based on Application, clinicians select devices for Cardiac Arrest, Oncology, Orthopedics, Pediatrics, and Trauma, where Cardiac Arrest use occurs both In-Hospital and Out-Of-Hospital, Oncology supports Bone Marrow Biopsy and Chemotherapy Support, Orthopedics addresses Fracture Repair and Joint Replacement, Pediatrics spans Child, Infant, and Neonatal populations, and Trauma care must cover Blunt and Penetrating injuries. Finally, clinical indication profiles matter deeply. Based on Indication, device deployment is guided by conditions such as Cardiac Arrest, Hypovolemic Shock, Sepsis, and Trauma, each carrying unique procedural timing, access site considerations, and downstream therapy needs. Synthesizing these segmentation axes clarifies that a one-size-fits-all product rarely satisfies diverse use cases, and that tailored design, training, and support models are critical to adoption.

How regional regulatory, procurement, and clinical training differences in major global regions recalibrate product strategies and distribution models for intraosseous devices

Regional dynamics play a decisive role in shaping regulatory pathways, reimbursement frameworks, training ecosystems, and supply chain architectures for intraosseous devices. In the Americas, buyers emphasize rapid emergency care integration, wide availability of simulation training centers, and concentrated procurement through integrated health systems and large distributors, which favors devices with strong clinical evidence and scalable service models. In Europe, Middle East & Africa the regulatory mosaic and heterogeneous reimbursement practices create diverse entry conditions; European markets often prioritize clinical outcomes and post-market vigilance while Middle Eastern and African settings place a higher premium on device robustness and supply continuity, especially for remote or austere environments. In Asia-Pacific, rapid hospital expansion, increasing emergency care capacity, and significant military modernization programs create growing demand, but market access strategies must account for varied regulatory requirements, local manufacturing incentives, and differing clinician training norms.

Across these regions, local manufacturing capacity, tariff regimes, and logistics infrastructure influence lead times and inventory strategies. Regional purchasing consortia and tender processes can advantage manufacturers that offer transparent lifecycle support and training partnerships. Moreover, clinical guideline adoption and pre-hospital care models vary by region, which affects the segmentation of devices between in-hospital emergency departments and pre-hospital or military deployments. Consequently, successful regional strategies require tailored value propositions that align device features with local clinical workflows, regulatory expectations, and procurement mechanisms.

Competitive landscape analysis showing how evidence, training, and supply chain partnerships determine commercial success for intraosseous device providers

Competitive positioning within the intraosseous device segment reflects a mix of established device manufacturers, technology-focused entrants, and service-oriented providers that bundle training and post-market support with hardware sales. Leading players typically differentiate on clinical evidence, insertion reliability, and comprehensive service programs that include hands-on training, simulation modules, and competency validation. Emerging companies focus on niche advantages such as optimized ergonomics for pediatric populations, ultra-compact designs for air ambulance use, or integrated telemetry and tracking features that support inventory management and clinical documentation.

Partnerships and strategic alliances are increasingly common as companies seek to combine distribution strengths, clinical training capabilities, and manufacturing scale. Contract manufacturing and original equipment manufacturer relationships allow technology-focused entrants to accelerate market entry while mitigating capital investment in production facilities. Meanwhile, procurement groups and large health systems exert negotiating leverage through long-term purchasing agreements and by prioritizing suppliers who demonstrate supply chain transparency and robust post-market surveillance. Overall, competitive success depends on a coherent value proposition that pairs differentiated device performance with evidence-based outcomes, regulatory compliance, and scalable service delivery.

Actionable strategic blueprint for manufacturers and health system leaders to secure clinical adoption, supply continuity, and evidence-based differentiation in intraosseous devices

Industry leaders should adopt a multi-layered strategy that balances innovation with operational resilience to capture clinical trust and procurement preference. First, prioritize generation of high-quality clinical evidence that demonstrates improved first-attempt success rates, reduced insertion complications, and measurable workflow efficiencies; this evidence should underpin product claims and be integrated into clinician training curricula. Second, diversify supply chains by qualifying alternate component suppliers and by evaluating regional manufacturing partnerships to reduce exposure to tariff shocks and logistics disruptions. Third, design configurable product portfolios and modular training programs that address the needs of distinct end users, from ambulatory surgical centers and physician clinics to air ambulance teams and combat support medical units.

Additionally, invest in post-market services and digital tools that enhance device tracking, competency assessment, and real-world evidence collection; these services strengthen customer relationships and support reimbursement discussions. Engage proactively with payers, health systems, and regulatory authorities to clarify device classifications and to streamline adoption pathways. Finally, embed scenario planning for policy shifts and supply interruptions into commercial contracts and inventory practices so that clinical continuity remains protected during periods of heightened risk. By operationalizing these steps, manufacturers and distributors can reduce procurement friction, accelerate clinical acceptance, and preserve revenue stability in an evolving landscape.

Transparent mixed-methods research design integrating primary clinician interviews, regulatory review, and supply chain mapping to produce validated operational insights

The research approach underpinning this analysis combines primary qualitative engagement with key stakeholders, systematic review of regulatory and clinical literature, and targeted supply chain mapping to ensure robust, actionable insights. Primary research included structured interviews with practicing clinicians across emergency departments, intensive care units, air ambulance services, field medical units, and outpatient surgical centers, as well as discussions with procurement leaders, training program directors, and manufacturing partners. These conversations were designed to surface device performance priorities, training gaps, procurement criteria, and supply chain vulnerabilities.

Secondary research encompassed review of clinical guidelines, device instruction sets, regulatory filings, and published post-market surveillance summaries to corroborate clinician-reported outcomes and to understand device safety profiles. Supply chain analysis mapped key component suppliers, manufacturing footprints, and logistics routes to evaluate exposure to tariff changes and to identify practical mitigation options. Where appropriate, findings were validated through triangulation across multiple sources and via expert panel review. Methodological limitations include variable availability of institution-level procurement contracts and heterogeneity in training program adoption rates, which were mitigated by sourcing diverse respondent types and by clearly documenting areas of uncertainty for readers to consider in decision-making.

Synthesis of clinical, technological, and operational drivers defining the enduring value proposition for intraosseous infusion devices in acute care

Intraosseous infusion devices are a mature but evolving category that sits at the intersection of acute clinical need, technological innovation, and complex procurement dynamics. The trajectory of adoption is shaped less by single product attributes and more by an ecosystem of clinical evidence, supply chain resilience, training support, and regulatory alignment. Stakeholders who can synthesize these elements into coherent value propositions-providing demonstrable clinical benefits, reliable supply, and end-user training-will be best positioned to win durable adoption across emergency medicine, critical care, outpatient surgical settings, and military applications.

Looking ahead, policy and trade dynamics will continue to affect sourcing decisions and cost structures, making diversification and localized capacity valuable strategic levers. Equally, ongoing improvements in device ergonomics, insertion reliability, and integrated services such as simulation-based training will lower barriers to use and expand clinical indications. Ultimately, success for manufacturers and health systems alike depends on translating technical performance into measurable clinical outcomes and operational predictability, thereby ensuring that clinicians have the tools and confidence needed to deliver lifesaving care when time and access matter most.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of battery-powered automated intraosseous infusion systems in emergency care settings for faster vascular access
  • 5.2. Integration of smart sensor technology in intraosseous infusion devices to monitor flow rates and prevent complications
  • 5.3. Collaborative partnerships between medical device companies and trauma centers to refine intraosseous device design and training
  • 5.4. Growing demand for multi-site intraosseous access devices enabling simultaneous infusions in pediatric and adult patients
  • 5.5. Regulatory approvals and clinical trial outcomes driving commercialization of next-generation intraosseous infusion needles
  • 5.6. Rising investment in developing minimally invasive intraosseous catheters with enhanced biocompatible coatings for infection control
  • 5.7. Expansion of point-of-care intraosseous infusion solutions in military and austere environments to improve battlefield trauma care
  • 5.8. Ongoing research into ultra-thin intraosseous needles to reduce insertion pain and accelerate emergency pediatric resuscitation
  • 5.9. Development of integrated intraosseous infusion kits with prefilled saline lock and automated pressure monitoring systems
  • 5.10. Increase in tele-mentoring programs for remote intraosseous infusion training using augmented reality guidance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraosseous Infusion Devices Market, by Device Type

  • 8.1. Battery Powered Drill
  • 8.2. Manual Needles
  • 8.3. Pneumatic
  • 8.4. Spring Loaded Auto Insert

9. Intraosseous Infusion Devices Market, by End User

  • 9.1. Ambulatory Care Centers
    • 9.1.1. Outpatient Surgical Centers
    • 9.1.2. Physician Clinics
  • 9.2. Emergency Medical Services
    • 9.2.1. Air Ambulance
    • 9.2.2. Pre-Hospital Emergency Services
  • 9.3. Hospitals
    • 9.3.1. Emergency Department
      • 9.3.1.1. Adult Emergency Department
      • 9.3.1.2. Pediatric Emergency Department
    • 9.3.2. ICU
      • 9.3.2.1. Adult ICU
      • 9.3.2.2. Neonatal ICU
      • 9.3.2.3. Pediatric ICU
    • 9.3.3. Operating Room
      • 9.3.3.1. General Surgery
      • 9.3.3.2. Orthopedic Surgery
  • 9.4. Military
    • 9.4.1. Combat Support Hospitals
    • 9.4.2. Field Medical Units

10. Intraosseous Infusion Devices Market, by Technology

  • 10.1. Battery Powered
    • 10.1.1. Rechargeable Battery
    • 10.1.2. Single Use Battery
  • 10.2. Manual
  • 10.3. Pneumatic
    • 10.3.1. Air Driven
    • 10.3.2. Gas Driven
  • 10.4. Spring Mechanism

11. Intraosseous Infusion Devices Market, by Application

  • 11.1. Cardiac Arrest
    • 11.1.1. In-Hospital
    • 11.1.2. Out-Of-Hospital
  • 11.2. Oncology
    • 11.2.1. Bone Marrow Biopsy
    • 11.2.2. Chemotherapy Support
  • 11.3. Orthopedics
    • 11.3.1. Fracture Repair
    • 11.3.2. Joint Replacement
  • 11.4. Pediatrics
    • 11.4.1. Child
    • 11.4.2. Infant
    • 11.4.3. Neonatal
  • 11.5. Trauma
    • 11.5.1. Blunt
    • 11.5.2. Penetrating

12. Intraosseous Infusion Devices Market, by Indication

  • 12.1. Cardiac Arrest
  • 12.2. Hypovolemic Shock
  • 12.3. Sepsis
  • 12.4. Trauma

13. Intraosseous Infusion Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intraosseous Infusion Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intraosseous Infusion Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Becton, Dickinson and Company
    • 16.3.2. Teleflex Incorporated
    • 16.3.3. Cook Group Incorporated
    • 16.3.4. Vygon SA
    • 16.3.5. ICU Medical, Inc.
    • 16.3.6. Smiths Group plc
    • 16.3.7. B. Braun Melsungen AG
    • 16.3.8. Merit Medical Systems, Inc.
    • 16.3.9. Nipro Corporation
    • 16.3.10. Waismed Strategic Technologies Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INTRAOSSEOUS INFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INTRAOSSEOUS INFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAOSSEOUS INFUSION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED DRILL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING LOADED AUTO INSERT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PHYSICIAN CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR AMBULANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PRE-HOSPITAL EMERGENCY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT EMERGENCY DEPARTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC EMERGENCY DEPARTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ICU, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY NEONATAL ICU, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MILITARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY COMBAT SUPPORT HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FIELD MEDICAL UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SINGLE USE BATTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY AIR DRIVEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY GAS DRIVEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY SPRING MECHANISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY IN-HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY OUT-OF-HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY CHEMOTHERAPY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY FRACTURE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL INTRAOSSEOUS INFUSION DEVICES MARKET SIZE, BY PEDIATRI